atenolol has been researched along with disopyramide in 36 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (27.78) | 18.7374 |
1990's | 8 (22.22) | 18.2507 |
2000's | 11 (30.56) | 29.6817 |
2010's | 6 (16.67) | 24.3611 |
2020's | 1 (2.78) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Esaki, T; Kawashima, H; Komura, H; Kuroda, M; Mizuguchi, K; Natsume-Kitatani, Y; Ohashi, R; Watanabe, R | 1 |
Breithardt, G; Jochum, E; Kuhn, H; Seipel, L | 1 |
Elliott, L; Grubb, BP; Hahn, H; Madu, E; Samoil, D; Temesy-Armos, P; Wolfe, D | 1 |
Enquist, M; Hermansson, J | 1 |
Angelo, HR; Bonde, J; Kampmann, JP; Pedersen, LE; Svendsen, TL; Trap-Jensen, J | 1 |
Angelo, HR; Bonde, J; Bødtker, S; Kampmann, JP; Svendsen, TL | 1 |
Wilcox, RG | 1 |
Ahokas, JT; Davies, C; Ravenscroft, PJ | 1 |
Bracchetti, D; Capucci, A; Catena, G; Lamberti, C; Magnani, B; Marchesini, B; Naccarella, F | 1 |
Jewitt, DE | 1 |
Van Durme, JP | 1 |
Walden, RJ | 1 |
Calkins, H; Morady, F; Seifert, M | 1 |
Bou-Holaigah, I; Calkins, H; Kan, JS; Rowe, PC | 1 |
Arita, M; Hara, M; Inoue, T; Ito, M; Maeda, T; Nakagawa, M; Saikawa, T; Shimoyama, N; Takaki, R; Yonemochi, H | 1 |
Camm, AJ; Guo, X; Hnatkova, K; Malik, M; Murgatroyd, FD | 1 |
Camm, AJ; Gallagher, MM; Guo, X; Hnatkova, K; Malik, M; Murgatroyd, FD; Waktare, JE | 1 |
Camm, AJ; Guo, X; Hnatkova, K; Malik, M; Murgatroyd, FD; Waktare, JE | 1 |
Dohmoto, H; Hashimoto, K; Sugiyama, A; Takahara, A; Yoshimoto, R | 1 |
Date, H; Emori, T; Kajiya, M; Matsubara, H; Miyaji, K; Morita, H; Nakamura, K; Ohe, T; Tani, Y | 1 |
Bando, T; Chen, F; Fujinaga, T; Hanaoka, N; Hasegawa, S; Sakai, H; Shoji, T | 1 |
Elliott, P; Morgagni, R; Pasquale, F; Tomé-Esteban, MT | 1 |
2 review(s) available for atenolol and disopyramide
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Hemodynamic effects of newer antiarrhythmic drugs.
Topics: Acebutolol; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Atenolol; Benzeneacetamides; Disopyramide; Dogs; Hemodynamics; Humans; Mexiletine; Piperidines; Tocainide; Verapamil | 1980 |
9 trial(s) available for atenolol and disopyramide
Article | Year |
---|---|
Anti-dysrhythmic treatment in acute myocardial infarction.
Topics: Acute Disease; Administration, Oral; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Humans; Injections, Intravenous; Lidocaine; Myocardial Infarction; Oxprenolol; Propranolol; Ventricular Fibrillation | 1979 |
[The effect of some antiarrhythmic drugs on systolic time intervals in normal subjects (author's transl)].
Topics: Adult; Ajmaline; Anti-Arrhythmia Agents; Atenolol; Blood Pressure; Clinical Trials as Topic; Depression, Chemical; Disopyramide; Humans; Myocardial Contraction; Propiophenones; Propranolol; Quinidine; Systole; Time Factors | 1978 |
Haemodynamic effects and kinetics of concomitant intravenous disopyramide and atenolol in patients with ischaemic heart disease.
Topics: Aged; Atenolol; Coronary Disease; Disopyramide; Drug Therapy, Combination; Female; Heart Rate; Hemodynamics; Humans; Kinetics; Male; Middle Aged; Stroke Volume | 1986 |
Acute intervention studies in patients with myocardial infarction using atenolol, propranolol, oxprenolol and disopyramide phosphate.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Atenolol; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Female; Humans; Male; Middle Aged; Myocardial Infarction; Oxprenolol; Propranolol; Pyridines | 1981 |
[Comparison of disopyramide and atenolol in the therapy of stabilized ventricular extrasystole in patients with mitral valve prolapse].
Topics: Adult; Atenolol; Cardiac Complexes, Premature; Disopyramide; Female; Heart Ventricles; Humans; Male; Middle Aged; Mitral Valve Prolapse; Pyridines | 1981 |
Evaluation of the antiarrhythmic efficacy of mexiletine in patients with chronic ventricular arrhythmias.
Topics: Arrhythmias, Cardiac; Atenolol; Chronic Disease; Clinical Trials as Topic; Disopyramide; Double-Blind Method; Electrocardiography; Exercise Test; Heart Ventricles; Humans; Mexiletine; Propylamines | 1980 |
Graphical representation of complex data--diurnal patterns of initiations of atrial fibrillation episodes.
Topics: Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Circadian Rhythm; Computer Graphics; Cross-Over Studies; Digoxin; Disopyramide; Double-Blind Method; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Probability | 1997 |
Evolution of changes in the ventricular rhythm during paroxysmal atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Cross-Over Studies; Digoxin; Disopyramide; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Time Factors | 1998 |
Age and gender influences on rate and duration of paroxysmal atrial fibrillation.
Topics: Age Factors; Aged; Anti-Arrhythmia Agents; Atenolol; Atrial Fibrillation; Cross-Over Studies; Digoxin; Disopyramide; Double-Blind Method; Electrocardiography, Ambulatory; Female; Heart Rate; Humans; Male; Middle Aged; Sex Factors; Signal Processing, Computer-Assisted; Time Factors | 1998 |
25 other study(ies) available for atenolol and disopyramide
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Development of an
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Cell Line; Computer Simulation; Endothelial Cells; Gene Knockout Techniques; Humans; Organic Chemicals; Rats, Transgenic | 2021 |
Recurrent unexplained syncope in the elderly: the use of head-upright tilt table testing in evaluation and management.
Topics: Aged; Aged, 80 and over; Atenolol; Beds; Blood Pressure; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Female; Head; Humans; Isoproterenol; Male; Monitoring, Physiologic; Posture; Prospective Studies; Recurrence; Scopolamine; Syncope | 1992 |
Separation and quantitation of (R)- and (S)-atenolol in human plasma and urine using an alpha 1-AGP column.
Topics: Atenolol; Chromatography; Chromatography, High Pressure Liquid; Disopyramide; Humans; Male; Orosomucoid; Spectrometry, Fluorescence; Stereoisomerism | 1989 |
Atenolol inhibits the elimination of disopyramide.
Topics: Adult; Aged; Atenolol; Coronary Disease; Dealkylation; Disopyramide; Female; Half-Life; Humans; Kinetics; Male | 1985 |
Comparison of beta-adrenoceptor antagonists as modulators of drug metabolism: effect of lipophilicity on microsomal phase I and II reactions.
Topics: 7-Alkoxycoumarin O-Dealkylase; Adrenergic beta-Antagonists; Animals; Atenolol; Chemical Phenomena; Chemistry, Physical; Cytochrome P-450 CYP1A1; Disopyramide; In Vitro Techniques; Microsomes, Liver; Oxidoreductases; Oxygenases; Pharmaceutical Preparations; Propranolol; Rats; Solubility | 1984 |
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
Topics: Atenolol; Disopyramide; Fatigue Syndrome, Chronic; Humans; Hypotension; Tilt-Table Test | 1995 |
Clinical presentation and long-term follow-up of athletes with exercise-induced vasodepressor syncope.
Topics: Adolescent; Adult; Age of Onset; Atenolol; Bradycardia; Disopyramide; Drug Combinations; Exercise; Exercise Test; Female; Follow-Up Studies; Humans; Hypotension, Orthostatic; Male; Middle Aged; Monitoring, Physiologic; Recurrence; Sports; Syncope; Tilt-Table Test | 1995 |
Is neurally mediated hypotension an unrecognised cause of chronic fatigue?
Topics: Adolescent; Atenolol; Autonomic Nervous System Diseases; Blood Pressure; Child; Disopyramide; Fatigue Syndrome, Chronic; Female; Humans; Hypotension; Male; Posture; Syncope; Tilt-Table Test | 1995 |
Suppression of ventricular premature contractions continues after the washout of antiarrhythmic drugs.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atenolol; Disopyramide; Electrocardiography, Ambulatory; Female; Humans; Male; Mexiletine; Middle Aged | 1993 |
Cardiovascular action of a cardioselective Ca(2+)channel blocker AH-1058 in conscious dogs assessed by telemetry.
Topics: Animals; Atenolol; Blood Pressure; Bridged Bicyclo Compounds; Calcium Channel Blockers; Cardiovascular System; Consciousness; Disopyramide; Dogs; Heart Rate; Hemodynamics; Male; Piperidines; Substrate Specificity; Telemetry; Ventricular Pressure; Verapamil | 2001 |
Failure of disopyramide to improve right ventricular outflow tract obstruction after living-donor lobar lung transplantation.
Topics: Adult; Anti-Arrhythmia Agents; Atenolol; Cardiac Catheterization; Disopyramide; Echocardiography; Female; Heart; Hemodynamics; Humans; Living Donors; Lung Transplantation; Retreatment; Treatment Failure; Ventricular Outflow Obstruction | 2004 |
Right ventricular outflow tract obstruction after bilateral lung transplantation.
Topics: Adult; Atenolol; Cardiac Surgical Procedures; Cardiovascular Agents; Disopyramide; Drug Therapy, Combination; Female; Heart Septal Defects, Atrial; Hemodynamics; Humans; Hypertension, Pulmonary; Lung Transplantation; Radiography; Treatment Outcome; Ventricular Outflow Obstruction | 2009 |
Provokable left ventricular outflow tract obstruction in a patient without hypertrophy.
Topics: Angina Pectoris; Anti-Arrhythmia Agents; Atenolol; Cardiac Pacing, Artificial; Diagnostic Imaging; Disopyramide; Drug Administration Schedule; Drug Therapy, Combination; Dyspnea; Heart Function Tests; Humans; Hypertrophy, Left Ventricular; Male; Middle Aged; Risk Factors; Treatment Outcome; Ventricular Outflow Obstruction | 2009 |